Cohen Jessica, Ortiz Olivia, Llaguno Silvia Elena, Goodyear Lorelei, Billings Deborah, Martinez Imelda
PATH, Seattle, WA, USA.
Reprod Health Matters. 2005 Nov;13(26):84-92. doi: 10.1016/S0968-8080(05)26202-X.
In Latin America, where restrictive laws limit women's access to safe abortion services, misoprostol is being used to induce abortions, often without correct information on dosage or regimens. This study in an unnamed Latin American country aimed to identify appropriate channels through which instructions on misoprostol use could be disseminated to women. In-depth interviews were carried out with physicians, pharmacy staff, women who had had safe abortions and women from the community, as well as focus group discussions with advocates of safe abortion. Participants considered physicians to be the most appropriate source of information and for ensuring confidentiality for both women and provider. Participants considered midwives, pharmacists and women's groups as appropriate referral points, but not providers of information. Legal restrictions and professional risk were the primary reasons why pharmacists rejected this role, though many are selling misoprostol. There was a general lack of information about misoprostol for medical abortion among both health professionals and women. Accurate information about misoprostol use for a wide range of gynaecologic and obstetric purposes, including induced abortion, could be incorporated into training and educational materials for physicians, midwives and other appropriate mid-level providers, as well as pharmacists. Without these alternative information channels, access to information would be severely restricted, especially in rural areas.
在拉丁美洲，严格的法律限制了妇女获得安全堕胎服务的机会，米索前列醇正被用于诱导堕胎，而且往往没有关于剂量或用药方案的正确信息。这项在一个未具名的拉丁美洲国家开展的研究旨在确定能够将米索前列醇使用说明传播给女性的合适渠道。研究人员对医生、药房工作人员、有过安全堕胎经历的女性以及社区女性进行了深入访谈，并与安全堕胎倡导者进行了焦点小组讨论。参与者认为医生是最合适的信息来源，且能确保女性和提供者双方的隐私。参与者认为助产士、药剂师和妇女团体是合适的转诊点，但不是信息提供者。法律限制和职业风险是药剂师拒绝承担这一角色的主要原因，尽管许多药剂师在售卖米索前列醇。卫生专业人员和女性普遍缺乏关于米索前列醇用于药物流产的信息。关于米索前列醇在包括诱导堕胎在内的广泛妇科和产科用途方面的准确信息，可以纳入医生、助产士和其他合适的中级医疗服务提供者以及药剂师的培训和教育材料中。如果没有这些替代信息渠道，获取信息将受到严重限制，尤其是在农村地区。
